4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-008124
Director sold 13,471 shares at $9.86 ($132,851)
From the SEC's structured data for this filing
Trades in this filing
Kauffman Michael · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-07 | Sale : show line 1 in the form | −6,764 | $9.86 | $66,707 | 708,062 | D |
| 2022-02-07 | Sale : show line 2 in the form | −6,707 | $9.86 | $66,144 | 913,445 | I |
| Open-market sales · 13,471 sh · avg $9.86 · $132,851 | ||||||
Loading xslF345X03/doc4.xml…